Cancers,
Journal Year:
2024,
Volume and Issue:
16(19), P. 3351 - 3351
Published: Sept. 30, 2024
Purpose:
To
develop
and
validate
an
MRI-based
radiomic
model
for
predicting
overall
survival
(OS)
in
patients
diagnosed
with
glioblastoma
multiforme
(GBM),
utilizing
a
retrospective
dataset
from
multiple
institutions.
Materials
Methods:
Pre-treatment
MRI
images
of
289
GBM
were
collected.
From
each
patient’s
tumor
volume,
660
features
(RFs)
extracted
subjected
to
robustness
analysis.
The
initial
prognostic
minimum
RFs
was
subsequently
enhanced
by
including
clinical
variables.
final
clinical–radiomic
derived
through
repeated
three-fold
cross-validation
on
the
training
dataset.
Performance
evaluation
included
assessment
concordance
index
(C-Index),
integrated
area
under
curve
(iAUC)
alongside
patient
stratification
into
low
high-risk
groups
(OS).
Results:
model,
which
has
highest
level
interpretability,
utilized
primary
gross
volume
(GTV)
one
modality
(T2-FLAIR)
as
predictor
age
variable
two
independent,
robust
RFs,
achieving
moderately
good
discriminatory
performance
(C-Index
[95%
confidence
interval]:
0.69
[0.62–0.75])
significant
(p
=
7
×
10−5)
validation
cohort.
Furthermore,
trained
exhibited
iAUC
at
11
months
(0.81)
literature.
Conclusion:
We
identified
validated
based
OS
using
multicenter
Future
work
will
focus
use
deep
learning-based
features,
recently
standardized
convolutional
filters
tasks.
Seminars in Cancer Biology,
Journal Year:
2023,
Volume and Issue:
93, P. 97 - 113
Published: May 19, 2023
Lung
cancer
is
the
leading
cause
of
cancer-related
deaths
worldwide.
It
exhibits,
at
mesoscopic
scale,
phenotypic
characteristics
that
are
generally
indiscernible
to
human
eye
but
can
be
captured
non-invasively
on
medical
imaging
as
radiomic
features,
which
form
a
high
dimensional
data
space
amenable
machine
learning.
Radiomic
features
harnessed
and
used
in
an
artificial
intelligence
paradigm
risk
stratify
patients,
predict
for
histological
molecular
findings,
clinical
outcome
measures,
thereby
facilitating
precision
medicine
improving
patient
care.
Compared
tissue
sampling-driven
approaches,
radiomics-based
methods
superior
being
non-invasive,
reproducible,
cheaper,
less
susceptible
intra-tumoral
heterogeneity.
This
review
focuses
application
radiomics,
combined
with
intelligence,
delivering
lung
treatment,
discussion
centered
pioneering
groundbreaking
works,
future
research
directions
area.
Diagnostics,
Journal Year:
2024,
Volume and Issue:
14(8), P. 848 - 848
Published: April 19, 2024
The
rapid
advancement
of
artificial
intelligence
(AI)
has
significantly
impacted
various
aspects
healthcare,
particularly
in
the
medical
imaging
field.
This
review
focuses
on
recent
developments
application
deep
learning
(DL)
techniques
to
breast
cancer
imaging.
DL
models,
a
subset
AI
algorithms
inspired
by
human
brain
architecture,
have
demonstrated
remarkable
success
analyzing
complex
images,
enhancing
diagnostic
precision,
and
streamlining
workflows.
models
been
applied
diagnosis
via
mammography,
ultrasonography,
magnetic
resonance
Furthermore,
DL-based
radiomic
approaches
may
play
role
risk
assessment,
prognosis
prediction,
therapeutic
response
monitoring.
Nevertheless,
several
challenges
limited
widespread
adoption
clinical
practice,
emphasizing
importance
rigorous
validation,
interpretability,
technical
considerations
when
implementing
solutions.
By
examining
fundamental
concepts
synthesizing
latest
advancements
trends,
this
narrative
aims
provide
valuable
up-to-date
insights
for
radiologists
seeking
harness
power
care.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: April 20, 2023
Abstract
For
accurate
diagnosis
of
interstitial
lung
disease
(ILD),
a
consensus
radiologic,
pathological,
and
clinical
findings
is
vital.
Management
ILD
also
requires
thorough
follow-up
with
computed
tomography
(CT)
studies
function
tests
to
assess
progression,
severity,
response
treatment.
However,
classification
subtypes
can
be
challenging,
especially
for
those
not
accustomed
reading
chest
CTs
regularly.
Dynamic
models
predict
patient
survival
rates
based
on
longitudinal
data
are
challenging
create
due
complexity,
variation,
irregular
visit
intervals.
Here,
we
utilize
RadImageNet
pretrained
diagnose
five
types
multimodal
transformer
model
determine
patient’s
3-year
rate.
When
history
associated
CT
scans
available,
the
proposed
deep
learning
system
help
clinicians
classify
patients
and,
importantly,
dynamically
progression
prognosis.
Investigative Radiology,
Journal Year:
2023,
Volume and Issue:
unknown
Published: April 12, 2023
Abstract
Interstitial
lung
disease
(ILD)
is
now
diagnosed
by
an
ILD-board
consisting
of
radiologists,
pulmonologists,
and
pathologists.
They
discuss
the
combination
computed
tomography
(CT)
images,
pulmonary
function
tests,
demographic
information,
histology
then
agree
on
one
200
ILD
diagnoses.
Recent
approaches
employ
computer-aided
diagnostic
tools
to
improve
detection
disease,
monitoring,
accurate
prognostication.
Methods
based
artificial
intelligence
(AI)
may
be
used
in
computational
medicine,
especially
image-based
specialties
such
as
radiology.
This
review
summarises
highlights
strengths
weaknesses
latest
most
significant
published
methods
that
could
lead
a
holistic
system
for
diagnosis.
We
explore
current
AI
data
use
predict
prognosis
progression
ILDs.
It
essential
highlight
holds
information
related
risk
factors
progression,
e.g.,
CT
scans
tests.
aims
identify
potential
gaps,
areas
require
further
research,
combined
yield
more
promising
results
future
studies.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(3), P. 674 - 674
Published: Feb. 5, 2024
(1)
Background:
Lung
cancer's
high
mortality
due
to
late
diagnosis
highlights
a
need
for
early
detection
strategies.
Artificial
intelligence
(AI)
in
healthcare,
particularly
lung
cancer,
offers
promise
by
analyzing
medical
data
identification
and
personalized
treatment.
This
systematic
review
evaluates
AI's
performance
cancer
detection,
its
techniques,
strengths,
limitations,
comparative
edge
over
traditional
methods.
(2)
Methods:
meta-analysis
followed
the
PRISMA
guidelines
rigorously,
outlining
comprehensive
protocol
employing
tailored
search
strategies
across
diverse
databases.
Two
reviewers
independently
screened
studies
based
on
predefined
criteria,
ensuring
selection
of
high-quality
relevant
role
detection.
The
extraction
key
study
details
metrics,
quality
assessment,
facilitated
robust
analysis
using
R
software
(Version
4.3.0).
process,
depicted
via
flow
diagram,
allowed
meticulous
evaluation
synthesis
findings
this
review.
(3)
Results:
From
1024
records,
39
met
inclusion
showcasing
AI
model
applications
emphasizing
varying
strengths
among
studies.
These
underscore
potential
but
highlight
standardization
amidst
variations.
results
demonstrate
promising
pooled
sensitivity
specificity
0.87,
signifying
accuracy
identifying
true
positives
negatives,
despite
observed
heterogeneity
attributed
parameters.
(4)
Conclusions:
demonstrates
showing
levels
However,
variations
underline
standardized
protocols
fully
leverage
revolutionizing
diagnosis,
ultimately
benefiting
patients
healthcare
professionals.
As
field
progresses,
validated
models
from
large-scale
perspective
will
greatly
benefit
clinical
practice
patient
care
future.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(4), P. 831 - 831
Published: Feb. 19, 2024
Non-small
cell
lung
cancer
(NSCLC)
is
the
leading
cause
of
cancer-related
mortality
among
women
and
men,
in
developed
countries,
despite
public
health
interventions
including
tobacco-free
campaigns,
screening
early
detection
methods,
recent
therapeutic
advances,
ongoing
intense
research
on
novel
antineoplastic
modalities.
Targeting
oncogenic
driver
mutations
immune
checkpoint
inhibition
has
indeed
revolutionized
NSCLC
treatment,
yet
there
still
remains
unmet
need
for
robust
standardized
predictive
biomarkers
to
accurately
inform
clinical
decisions.
Artificial
intelligence
(AI)
represents
computer-based
science
concerned
with
large
datasets
complex
problem-solving.
Its
concept
brought
a
paradigm
shift
oncology
considering
its
immense
potential
improved
diagnosis,
treatment
guidance,
prognosis.
In
this
review,
we
present
current
state
AI-driven
applications
management,
particular
focus
radiomics
pathomics,
critically
discuss
both
existing
limitations
future
directions
field.
The
thoracic
community
should
not
be
discouraged
by
likely
long
road
AI
implementation
into
daily
practice,
as
transformative
impact
personalized
approaches
undeniable.
Biomarker Research,
Journal Year:
2024,
Volume and Issue:
12(1)
Published: Jan. 25, 2024
Abstract
Background
Accurate
prediction
of
tumor
molecular
alterations
is
vital
for
optimizing
cancer
treatment.
Traditional
tissue-based
approaches
encounter
limitations
due
to
invasiveness,
heterogeneity,
and
dynamic
changes.
We
aim
develop
validate
a
deep
learning
radiomics
framework
obtain
imaging
features
that
reflect
various
changes,
aiding
first-line
treatment
decisions
patients.
Methods
conducted
retrospective
study
involving
508
NSCLC
patients
from
three
institutions,
incorporating
CT
images
clinicopathologic
data.
Two
radiomic
scores
network
feature
were
constructed
on
data
sources
in
the
3D
region.
Using
these
features,
we
developed
validated
‘Deep-RadScore,’
model
predict
prognostic
factors,
gene
mutations,
immune
molecule
expression
levels.
Findings
The
Deep-RadScore
exhibits
strong
discrimination
features.
In
independent
test
cohort,
it
achieved
impressive
AUCs:
0.889
lymphovascular
invasion,
0.903
pleural
0.894
T
staging;
0.884
EGFR
ALK,
0.896
KRAS
PIK3CA,
TP53,
0.895
ROS1;
0.893
PD-1/PD-L1.
Fusing
yielded
optimal
predictive
power,
surpassing
any
single
feature.
Correlation
interpretability
analyses
confirmed
effectiveness
customized
capturing
additional
phenotypes
beyond
known
Interpretation
This
proof-of-concept
demonstrates
new
biomarkers
across
can
be
provided
by
fusing
multiple
sources.
holds
potential
offer
valuable
insights
radiological
phenotyping
characterizing
diverse
alterations,
thereby
advancing
pursuit
non-invasive
personalized